Suppr超能文献

采用 CK17、SOX2 和 GATA3 免疫组织化学方法诊断疣状棘皮瘤样外阴上皮内瘤变(vaVIN)。

Diagnosis of verruciform acanthotic vulvar intra-epithelial neoplasia (vaVIN) using CK17, SOX2 and GATA3 immunohistochemistry.

机构信息

Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

University Hospital Ghent, Ghent, Belgium.

出版信息

Histopathology. 2024 Jun;84(7):1212-1223. doi: 10.1111/his.15156. Epub 2024 Feb 14.

Abstract

AIMS

Verruciform acanthotic vulvar intra-epithelial neoplasia (vaVIN) is an HPV-independent, p53 wild-type lesion with distinct morphology and documented risk of recurrence and cancer progression. vaVIN is rare, and prospective distinction from non-neoplastic hyperplastic lesions can be difficult. CK17, SOX2 and GATA3 immunohistochemistry has emerging value in the diagnosis of HPV-independent lesions, particularly differentiated VIN. We aimed to test the combined value of these markers in the diagnosis of vaVIN versus its non-neoplastic differentials in the vulva.

METHODS AND RESULTS

CK17, SOX2 and GATA3 immunohistochemistry was evaluated on 16 vaVINs and 34 mimickers (verruciform xanthoma, lichen simplex chronicus, lichen sclerosus, psoriasis, pseudo-epitheliomatous hyperplasia). CK17 was scored as 3+ = full-thickness, 2+ = partial-thickness, 1+ = patchy, 0 = absent; SOX2 as 3+ = strong staining ≥ 10% cells, 2+ = moderate, 1 + =weak, 0 = staining in < 10% cells; and GATA3 as pattern 0 = loss in < 25% basal cells, 1 = loss in 25-75% basal cells, 2 = loss in > 75% basal cells. For analysis, results were recorded as positive (CK17 = 3+, SOX2 = 3+, GATA3 = patterns 1/2) or negative (CK17 = 2+/1+/0, SOX2 = 2+/1+/0, GATA3 = pattern 0). CK17, SOX2 and GATA3 positivity was documented in 81, 75 and 58% vaVINs, respectively, versus 32, 17 and 22% of non-neoplastic mimickers, respectively; ≥ 2 marker positivity conferred 83 sensitivity, 88 specificity and 86% accuracy in vaVIN diagnosis. Compared to vaVIN, SOX2 and GATA3 were differentially expressed in lichen sclerosus, lichen simplex chronicus and pseudo-epitheliomatous hyperplasia, whereas CK17 was differentially expressed in verruciform xanthoma and adjacent normal mucosa.

CONCLUSIONS

CK17, SOX2 and GATA3 can be useful in the diagnosis of vaVIN and its distinction from hyperplastic non-neoplastic vulvar lesions. Although CK17 has higher sensitivity, SOX2 and GATA3 are more specific, and the combination of all markers shows optimal diagnostic accuracy.

摘要

目的

疣状棘皮瘤样外阴上皮内瘤变(vaVIN)是一种 HPV 独立、p53 野生型病变,具有独特的形态,且有明确的复发和癌症进展风险。vaVIN 较为罕见,且与非肿瘤性增生性病变的前瞻性鉴别可能较为困难。CK17、SOX2 和 GATA3 免疫组化在 HPV 独立病变的诊断中具有潜在价值,特别是分化型 VIN。我们旨在检验这些标志物联合用于诊断 vaVIN 及其在外阴非肿瘤性病变中的鉴别诊断的价值。

方法和结果

对 16 例 vaVIN 和 34 例模拟病变(疣状黄色瘤、慢性单纯性苔藓、硬化性苔藓、银屑病、假上皮瘤样增生)进行了 CK17、SOX2 和 GATA3 免疫组化评估。CK17 的评分标准为 3+= 全层,2+= 部分层,1+= 斑片状,0= 无;SOX2 的评分标准为 3+= 阳性细胞强度≥10%,2+= 中度,1+= 弱阳性,0= 阳性细胞强度<10%;GATA3 的评分标准为 0= 基底细胞缺失<25%,1= 缺失 25-75%,2= 缺失>75%。分析时,结果记录为阳性(CK17=3+,SOX2=3+,GATA3=1/2 型)或阴性(CK17=2+/1+/0,SOX2=2+/1+/0,GATA3=0 型)。81%的 vaVIN 中 CK17、75%的 vaVIN 中 SOX2 和 58%的 vaVIN 中 GATA3 阳性,而非肿瘤性模拟病变中分别为 32%、17%和 22%;≥2 种标志物阳性时,vaVIN 的诊断敏感性为 83%,特异性为 88%,准确性为 86%。与 vaVIN 相比,SOX2 和 GATA3 在硬化性苔藓、慢性单纯性苔藓和假上皮瘤样增生中表达不同,而 CK17 在疣状黄色瘤和相邻正常黏膜中表达不同。

结论

CK17、SOX2 和 GATA3 可用于诊断 vaVIN 及其与增生性非肿瘤性外阴病变的鉴别诊断。虽然 CK17 的敏感性较高,但 SOX2 和 GATA3 的特异性更高,且所有标志物联合使用时诊断准确性最佳。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验